3 March 2022
U.K. SPAC PLC
(the "Company")
Extension of Warrants
As announced on 15 February 2021, pursuant to a placing to raise £3.1 million, the Company granted 1,584,810,126 warrants ("Warrants"), exercisable at a price of 0.3 pence per share, for a period of 12 months following the date of grant being 3 March 2021.
In light of the continuing progress of the transaction the Board of the Company has decided to extend the date by which they are to be exercised by 30 days so that they now expire on 4 April 2022. All other terms and conditions of the Warrants remain the same.
While the Board awaits the decision of the FCA regarding the Acquisition and readmission of the enlarged share capital to the Official List (by way of a Standard Listing) work continues to prepare for completion of the transaction. The Board looks forward to providing an update on the expected timetable as soon as practicably possible.
For further information, please visit http://www.ukspacplc.com or contact the following:
| U.K. SPAC Plc |
07500 558 235 |
| Peter Jay |
|
|
|
|
| Cairn Financial Advisers LLP |
020 7213 0880 |
| Jo Turner / Sandy Jamieson |
|
|
|
|
| Peterhouse Capital Limited |
020 7469 0930 |
| Lucy Williams / Duncan Vasey |
|
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.